Insider Transactions in Q2 2021 at Immunome Inc. (IMNM)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2021
|
Michael Rapp Director |
BUY
Open market or private purchase
|
Indirect |
2,300
+1.65%
|
$41,400
$18.94 P/Share
|
|
May 26
2021
|
Michael Lefenfeld Director |
BUY
Open market or private purchase
|
Direct |
1,335
+4.73%
|
$25,365
$19.03 P/Share
|
|
May 25
2021
|
Purnanand D Sarma President and CEO |
BUY
Open market or private purchase
|
Direct |
10,500
+50.0%
|
$189,000
$18.41 P/Share
|
|
May 25
2021
|
Michael Rapp Director |
BUY
Open market or private purchase
|
Indirect |
19,303
+12.55%
|
$347,454
$18.32 P/Share
|
|
May 25
2021
|
Michael Lefenfeld Director |
BUY
Open market or private purchase
|
Direct |
2,715
+9.61%
|
$48,870
$18.44 P/Share
|
|
May 24
2021
|
John L Lamattina Director |
BUY
Open market or private purchase
|
Direct |
5,440
+4.84%
|
$97,920
$18.51 P/Share
|
|
May 24
2021
|
Philip Wagenheim |
BUY
Open market or private purchase
|
Direct |
13,500
+3.29%
|
$243,000
$18.35 P/Share
|
|
May 24
2021
|
Michael Rapp Director |
BUY
Open market or private purchase
|
Indirect |
31,895
+21.68%
|
$574,110
$18.38 P/Share
|
|
May 24
2021
|
Michael Lefenfeld Director |
BUY
Open market or private purchase
|
Direct |
600
+2.56%
|
$10,200
$17.8 P/Share
|